Stay updated on Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.

Latest updates to the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page
- Check2 days agoChange DetectedThe page revision label changed from v3.5.3 to v3.5.4, indicating a newer version of the page content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page’s footer release revision/version was updated from **v3.5.2** to **v3.5.3** without any apparent change to the underlying study information.SummaryDifference0.1%

- Check30 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 in the page footer.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a backend version update with no user-facing changes.SummaryDifference0.1%

- Check95 days agoChange DetectedMinor version update noted: v3.4.2 has been added and v3.4.1 removed. This appears to be a maintenance change rather than a change to study data or user actions.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Plus SBRT in Metastatic RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus SBRT in Metastatic RCC Clinical Trial page.